CBD Research and Data
FDA’s November CBD Hearing Won't be What Industry Wants
November conference will focus on differing effects on each gender.
How CBD Has Performed During COVID
While a new report finds that 39% of consumers are using CBD more frequently as a result of COVID, the hemp-derived CBD market is not expected to meet 2020 sales projections.
Most CBD Labeling Accurate: Report
Independent testing shows 84% of products contain more cannabidiol than advertised
Update: A State-by-State Breakdown of CBD Laws
Regulatory outlook remains gray due to FDA uncertainty and mixed enforcement messages
CBD: A Golden Opportunity?
Retailers test the growth potential of cannabidiol products but remain cautious